Predicting changes in substance use following psychedelic experiences: natural language processing of psychedelic session narratives
This quantitative interview study (n=1141) applied a machine learning tool to analyze written reports of psychedelic experiences and predicted whether the participants could reduce substance abuse in response to using psychedelics with a 65% accuracy across three independently trained Natural Language Processing models.
Authors
- Albert Garcia-Romeu
- Matthew Johnson
Published
Abstract
Background
Experiences with psychedelic drugs, such as psilocybin or lysergic acid diethylamide (LSD), are sometimes followed by changes in patterns of tobacco, opioid, and alcohol consumption. But, the specific characteristics of psychedelic experiences that lead to changes in drug consumption are unknown.
Objective
Determine whether quantitative descriptions of psychedelic experiences derived using Natural Language Processing (NLP) would allow us to predict who would quit or reduce using drugs following a psychedelic experience.
Methods
We recruited 1141 individuals (247 female, 894 male) from online social media platforms who reported quitting or reducing using alcohol, cannabis, opioids, or stimulants following a psychedelic experience to provide a verbal narrative of the psychedelic experience they attributed as leading to their reduction in drug use. We used NLP to derive topic models that quantitatively described each participant’s psychedelic experience narrative. We then used the vector descriptions of each participant’s psychedelic experience narrative as input into three different supervised machine learning algorithms to predict long-term drug reduction outcomes.
Results
We found that the topic models derived through NLP led to quantitative descriptions of participant narratives that differed across participants when grouped by the drug class quit as well as the long-term quit/reduction outcomes. Additionally, all three machine learning algorithms led to similar prediction accuracy (~65%, CI = ±0.21%) for long-term quit/reduction outcomes.
Conclusions
Using machine learning to analyze written reports of psychedelic experiences may allow for accurate prediction of quit outcomes and what drug is quit or reduced within psychedelic therapy.
Research Summary of 'Predicting changes in substance use following psychedelic experiences: natural language processing of psychedelic session narratives'
Introduction
Research indicates that psychedelics can produce meaningful reductions in problematic substance use, with open-label and observational studies reporting improvements in tobacco, alcohol, and other substance use following experiences with agents such as psilocybin and LSD. Prior work has linked therapeutic benefits to acute subjective qualities of the psychedelic experience—particularly so-called mystical-type effects characterised by unity, positive mood, and ineffability—but objectively measuring those subjective experiences during sessions is difficult. Automated speech analysis during acute drug effects and post-session narrative analysis have both been proposed as ways to quantify subjective experience, and natural language processing (NLP) offers a potentially efficient, generalisable method to do so. Cox and colleagues set out to determine whether quantitative descriptions of retrospective psychedelic session narratives derived via NLP could (1) distinguish which drug class a person subsequently reduced or quit, (2) distinguish the extent of reduction/quit outcomes, and (3) predict long-term quit/reduction outcomes when those NLP outputs are used as inputs to supervised machine learning (ML) algorithms. The analysis used a large convenience sample of retrospective written narratives from people who reported a psychedelic experience as preceding a reduction or cessation in substance use.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Study Details
- Study Typeindividual
- Journal
- Topic
- Authors
- APA Citation
Cox, D. J., Garcia-Romeu, A., & Johnson, M. W. (2021). Predicting changes in substance use following psychedelic experiences: natural language processing of psychedelic session narratives. The American Journal of Drug and Alcohol Abuse, 47(4), 444-454. https://doi.org/10.1080/00952990.2021.1910830
References (17)
Papers cited by this study that are also in Blossom
Garcia-Romeu, A., Griffiths, R. R., Johnson, M. W. · Current Drug Abuse Reviews (2015)
Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P. et al. · Journal of Psychopharmacology (2014)
Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A. et al. · Journal of Psychopharmacology (2015)
Fábregas, J. M., González, D., Fondevila, S. et al. · Drug and Alcohol Dependence (2010)
Johnson, M. W., Hendricks, P. S., Barrett, F. S. et al. · Pharmacology and Therapeutics (2019)
Osmond, H. · Annals of the New York Academy of Sciences (2010)
Bedi, G., Cecchi, G. A., Slezak, D. F. et al. · Neuropsychopharmacology (2014)
Johnson, M. W., Richards, W. A., Griffiths, R. R. · Journal of Psychopharmacology (2008)
Carrillo, F., Sigman, M., Fernández Slezak, D. et al. · Journal of Affective Disorders (2018)
Zamberlan, F., Sanz, C., Pallavicini, C. et al. · Frontiers in Integrative Neuroscience (2018)
Show all 17 referencesShow fewer
Garcia-Romeu, A., Davis, A. K., Fire Erowid et al. · Journal of Psychopharmacology (2019)
Johnson, M. W., Garcia-Romeu, A., Johnson, P. S. et al. · Journal of Psychopharmacology (2017)
Bogenschutz, M. P., Pommy, J. A. · Drug Testing and Analysis (2012)
Grof, S., Goodman, L. E., Richards, W. A. · Pharmacopsychiatry (1973)
Pisano, V. D., Putnam, N. P., Kramer, H. M. et al. · Journal of Psychopharmacology (2017)
Johnson, M. W., Garcia-Romeu, A., Griffiths, R. R. · The American Journal of Drug and Alcohol Abuse (2016)
Uthaug, M. V., Van Oorsouw, &. K., Kuypers, &. K. P. C. et al. · Psychopharmacology (2018)
Cited By (5)
Papers in Blossom that reference this study
Peterson, A., Largent, E. A., Sisti, D. et al. · AJOB Neuroscience (2022)
Calleja-Conde, J., Morales-García, J. A., Echeverry-Alzate, V. et al. · Addiction Biology (2022)
Sanz, C., Cavanna, F., Muller, S. et al. · Psychopharmacology (2022)
Tagliazucchi, E. · Frontiers in Pharmacology (2022)
Dursun, S. M., Kelly, J. R., Gillan, C. M. et al. · Frontiers in Psychiatry (2021)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.